ASHLEY KLISZ: Open Payments
NPI 1225421373 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,771 in 104 payments from 34 companies in 2025. Trend: 2023 $5,092 · 2024 $7,300 · 2025 $2,771
Food & beverage: $2,771
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $403 |
| Axsome Therapeutics, Inc. | 6 | $314 |
| UCB, Inc. | 13 | $236 |
| Teva Pharmaceuticals USA, Inc. | 5 | $173 |
| Neurelis, Inc. | 3 | $169 |
| TG Therapeutics, Inc. | 2 | $159 |
| ACADIA Pharmaceuticals Inc | 3 | $134 |
| Amgen Inc. | 1 | $125 |
| EMD Serono, Inc. | 4 | $124 |
| Lundbeck LLC | 2 | $100 |
Products named: KESIMPTA, Symbravo, VALTOCO, AUSTEDO XR, BRIUMVI, NUPLAZID, Rystiggo, VYEPTI.
Industry payments across MI — which companies pay providers there.
